|
private:claritasgenomics
|
3182411
|
Feb 17th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 16th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 15th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 14th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 13th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 12th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 11th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 10th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 9th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|
|
private:claritasgenomics
|
3182411
|
Feb 8th, 2018 12:00AM
|
Claritas Genomics
|
2.2K
|
41.00
|
Open
|
Biotechnology
|
Feb 8th, 2017 11:57AM
|
Feb 8th, 2017 11:57AM
|
Claritas Genomics exists to radically change the field of pediatric genomic medicine by enabling the integration of genomics into clinical practice to inform, guide and improve medical treatment for kids around the world. As a result, we are more than a genetic testing laboratory. By combining the clinical expertise of the world’s best pediatric specialists with innovative patient-centric solutions to bioinformatics, reporting, and collaborative data sharing, we believe we will not only improve patient care, but also enable new discoveries to advance the field.
Through its partnerships and collaborations, Claritas has built an end-to-end system that incorporates best-in-class features from our partners. Our tests are conceived and developed in collaboration with the foremost clinical experts in pediatric medicine at Boston Children’s Hospital and Cincinnati Children’s Hospital. Through the integration of market-leading sequencing platforms from Illumina and Life Technologies with Cerner’s laboratory operations, analysis and reporting solutions, we perform diagnostic testing designed to provide pediatric patients and their families with answers in weeks. With our partner WuXi-NextCODE, we have built the infrastructure, tools, and connectivity needed to bring patient information to the investigators who can use the information individually to care for a specific patient and in aggregate to discover correlations that lead to enhanced clinical trial design and new treatment development.
|
|
|
|
|
|
|
|
|
|
Claritas Genomics
|
|
Pharmaceuticals & Biotechnology
|